San Diego

Report of blood clotting between use of CA Halt J&J vaccine

California – California stopped use of the Johnson & Johnson vaccine on Tuesday, expressing concern over reports of some serious blood clots, state officials confirmed.

The news comes after the federal government recommended an immediate stop in the nationwide use of the Johnson & Johnson vaccine after six US recipients – all women between 18 and 48 vaccinated for severe blood clots during 6 to 13 days goes.

One woman died, and another woman was hospitalized in Nebraska in critical condition.

California’s Johnson & Johnson Supply makes up 4 percent of the state’s allocation from the federal government this week.

He said California would follow the recommendations of the Centers for Disease Control and Prevention and the Food and Drug Administration and would “temporarily use the pause” of J&J out of “temporary precautions”.

“The FDA and CDC’s recommendation in California is being followed and directed health care providers to stop using the Johnson & Johnson vaccine until we receive guidelines from health and safety experts,” Dr. . Erica Pan, state epidemiologist, said in a joint statement. With the California Department of Public Health.

Supply of single-dose vaccines was already very limited due to a 15-million-dose batch that was wasted amid an ongoing conflict with a contracted manufacturer in Baltimore.

Stagnation “is important, in part, to ensure that the health care provider community is aware of the potential of these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clotting.” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research and CDC head deputy director Drs. Annie Shuchat said in a joint statement.

The statement said that over 6.8 million doses of the Jammu and Kashmir vaccine have been administered in the US. Federal officials reported that adverse reactions to the vaccine “appear to be extremely rare,” and that the CDC and FDA will work to review the six clotting cases in question.

“The treatment of this specific type of blood clot is different from the treatment that can usually be administered,” officials said. “Typically, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin can be dangerous, and requires alternative treatment.”

The CDC will convene a meeting of its advisory committee on vaccination practices on Wednesday to review cases and assess their potential importance.

According to news reports, Johnson & Johnson issued a statement, “Currently, no clear causal relationship has been established between these rare events and the company’s vaccines.” “We continue to work closely with experts and regulators to support open communication of this information to health care and the public,” J&J said.

California will call the Western States Scientific Safety Review Working Group to review the federal government’s reports.

The news could reopen California’s embraced vaccine rollout and Newsom’s goal by June 15, a decision that until then had endured most residents.

A drastic reduction in dosage supply in the Golden State was predicted this week after a drastic reduction in production of the Johnson & Johnson vaccine – and now that number could fall even further.

Nevertheless, Newsom said on Tuesday that “vaccines are still very safe. We are vaccinating 3+ million people a week and are still on track to reopen completely.”

“As stated by the federal government, we do not expect a significant impact to our vaccination allocation,” Pan said.

Newsom himself shot Johnson & Johnson on 1 April.

City News Service contributed to this report.

Back to top button